We are live on ! Find out more
VAM

Veritas Asset Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 3.19%
This Fund
S&P 500
This Quarter Est. Return
+12.45%
1 Year Est. Return
-3.19%
3 Year Est. Return
+26.61%
5 Year Est. Return
+23.16%
10 Year Est. Return
+201.18%
AUM
$4.95B
AUM Growth
+$725M
Cap. Flow
+$236M
Cap. Flow %
4.76%
Top 10 Hldgs %
80.08%
Holding
33
New
10
Increased
13
Reduced
Closed
5

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$210M
2
AGN
Allergan Inc
AGN
+$119M
3
QCOM icon
Qualcomm
QCOM
+$34.9M
4
C icon
Citigroup
C
+$30M
5
UNH icon
UnitedHealth
UNH
+$24.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.47%
2 Technology 28.01%
3 Industrials 12.99%
4 Communication Services 9.4%
5 Financials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.93T
$701M 14.16%
18,748,000
+334,000
+2% +$12.1M
LMT icon
2
Lockheed Martin
LMT
$117B
$642M 12.97%
4,318,962
+84,800
+2% +$11.5M
QCOM icon
3
Qualcomm
QCOM
$181B
$452M 9.12%
6,082,000
+494,600
+9% +$34.9M
UNH icon
4
UnitedHealth
UNH
$387B
$408M 8.25%
5,422,880
+346,500
+7% +$24.9M
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.22T
$405M 8.19%
14,520,222
+357,334
+3% +$9.04M
CVS icon
6
CVS Health
CVS
$137B
$335M 6.77%
4,685,020
+304,200
+7% +$19.5M
LH icon
7
Labcorp
LH
$23.2B
$276M 5.58%
3,519,959
+120,660
+4% +$10.3M
AGN
8
DELISTED
Allergan Inc
AGN
$258M 5.21%
2,324,200
+1,243,900
+115% +$119M
WAT icon
9
Waters Corp
WAT
$36.2B
$253M 5.11%
2,529,280
+121,600
+5% +$12.3M
NTRS icon
10
Northern Trust
NTRS
$34.2B
$234M 4.72%
3,778,850
ORCL icon
11
Oracle
ORCL
$364B
$234M 4.72%
+6,110,700
New +$210M
VAR
12
DELISTED
Varian Medical Systems, Inc.
VAR
$231M 4.66%
3,388,738
+150,759
+5% +$10M
C icon
13
Citigroup
C
$217B
$211M 4.25%
4,041,600
+593,500
+17% +$30M
BP icon
14
BP
BP
$108B
$169M 3.42%
4,261,799
SLB icon
15
SLB Ltd
SLB
$70.3B
$32.7M 0.66%
363,000
BIDU icon
16
Baidu
BIDU
$36.5B
$28.5M 0.57%
160,000
JOYY
17
JOYY Inc
JOYY
$3.53B
$16.1M 0.32%
+320,000
New +$15.9M
NTES icon
18
NetEase
NTES
$84.1B
$15.7M 0.32%
1,000,000
BAX icon
19
Baxter International
BAX
$11.7B
$10.9M 0.22%
+289,221
New +$10.5M
RMD icon
20
ResMed
RMD
$28.9B
$9.42M 0.19%
200,000
+100,000
+100% +$5.06M
WX
21
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$6.91M 0.14%
+180,000
New +$5.68M
AZO icon
22
AutoZone
AZO
$49.7B
$4.97M 0.1%
+10,400
New +$4.67M
VIPS icon
23
Vipshop
VIPS
$6.96B
$4.18M 0.08%
+500,000
New +$3.81M
FNV icon
24
Franco-Nevada
FNV
$38.7B
$3.86M 0.08%
94,800
+13,500
+17% +$567K
HDB icon
25
HDFC Bank
HDB
$135B
$3.44M 0.07%
+400,000
New +$3.4M

Similar funds

Veritas Asset Management's Q4 2013 Portfolio in Review

As of Q4 2013, Veritas Asset Management held 33 positions worth $4.95B, up 17% from $4.23B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Veritas Asset Management deployed $236M of net new capital in Q4 2013, opening 10 new positions and adding to 13 existing holdings. Its largest new stake was Oracle: 6,110,700 shares worth $234M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

On the sell side, the most notable exit was VCA Inc., an estimated $221M sold.

  • Veritas Asset Management's largest Q4 2013 buy was Oracle: 6,110,700 shares worth $234M.
  • Veritas Asset Management added most to Allergan Inc in Q4 2013, an estimated $119M increase.
  • Veritas Asset Management fully exited VCA Inc. in Q4 2013, selling an estimated $221M.
  • Veritas Asset Management's ten largest holdings make up 80% of its $4.95B portfolio in Q4 2013.
  • Veritas Asset Management opened 10 new positions and closed 5 in Q4 2013.
  • Veritas Asset Management's portfolio value rose 17% quarter-over-quarter to $4.95B.

Based on Veritas Asset Management's 13F filing for Q4 2013, filed 4 Feb 2014.